351 related articles for article (PubMed ID: 7609750)
1. Time of onset of non-insulin-dependent diabetes mellitus and genetic variation in the beta 3-adrenergic-receptor gene.
Walston J; Silver K; Bogardus C; Knowler WC; Celi FS; Austin S; Manning B; Strosberg AD; Stern MP; Raben N
N Engl J Med; 1995 Aug; 333(6):343-7. PubMed ID: 7609750
[TBL] [Abstract][Full Text] [Related]
2. Association of a polymorphism in the beta 3-adrenergic-receptor gene with features of the insulin resistance syndrome in Finns.
Widén E; Lehto M; Kanninen T; Walston J; Shuldiner AR; Groop LC
N Engl J Med; 1995 Aug; 333(6):348-51. PubMed ID: 7609751
[TBL] [Abstract][Full Text] [Related]
3. Genetic variation in the beta 3-adrenergic receptor and an increased capacity to gain weight in patients with morbid obesity.
Clément K; Vaisse C; Manning BS; Basdevant A; Guy-Grand B; Ruiz J; Silver KD; Shuldiner AR; Froguel P; Strosberg AD
N Engl J Med; 1995 Aug; 333(6):352-4. PubMed ID: 7609752
[TBL] [Abstract][Full Text] [Related]
4. Molecular scanning for mutations in the beta 3-adrenergic receptor gene in Nauruans with obesity and noninsulin-dependent diabetes mellitus.
Silver K; Walston J; Wang Y; Dowse G; Zimmet P; Shuldiner AR
J Clin Endocrinol Metab; 1996 Nov; 81(11):4155-8. PubMed ID: 8923875
[TBL] [Abstract][Full Text] [Related]
5. Association of Trp64Arg mutation of the beta3-adrenergic-receptor with NIDDM and body weight gain.
Fujisawa T; Ikegami H; Yamato E; Takekawa K; Nakagawa Y; Hamada Y; Oga T; Ueda H; Shintani M; Fukuda M; Ogihara T
Diabetologia; 1996 Mar; 39(3):349-52. PubMed ID: 8721782
[TBL] [Abstract][Full Text] [Related]
6. Prevalence of the Trp64Arg missense mutation of the beta3-adrenergic receptor gene in Japanese subjects.
Ueda K; Tanizawa Y; Oota Y; Inoue H; Kizuki N; Inoue H; Tsukuda K; Asano T; Oka Y
Metabolism; 1997 Feb; 46(2):199-202. PubMed ID: 9030829
[TBL] [Abstract][Full Text] [Related]
7. [Insulin resistance and beta 3-adrenergic receptor function].
Kobayashi I; Ishigami T; Umemura S
Nihon Rinsho; 2000 Feb; 58(2):333-7. PubMed ID: 10707554
[TBL] [Abstract][Full Text] [Related]
8. Molecular scanning of the beta-3-adrenergic receptor gene in Pima Indians and Caucasians.
Silver K; Walston J; Yang Y; Pratley R; Ravussin E; Raben N; Shuldiner AR
Diabetes Metab Res Rev; 1999; 15(3):175-80. PubMed ID: 10441039
[TBL] [Abstract][Full Text] [Related]
9. TRP64ARG beta 3-adrenergic receptor and obesity in Mexican Americans.
Silver K; Mitchell BD; Walston J; Sorkin JD; Stern MP; Roth J; Shuldiner AR
Hum Genet; 1997 Dec; 101(3):306-11. PubMed ID: 9439659
[TBL] [Abstract][Full Text] [Related]
10. Pima Indians as a model to study the genetics of NIDDM.
Bogardus C; Lillioja S
J Cell Biochem; 1992 Apr; 48(4):337-43. PubMed ID: 1577873
[TBL] [Abstract][Full Text] [Related]
11. Screening for mtDNA diabetes mutations in Pima Indians with NIDDM.
Sepehrnia B; Prezant TR; Rotter JI; Pettitt DJ; Knowler WC; Fischel-Ghodsian N
Am J Med Genet; 1995 Mar; 56(2):198-202. PubMed ID: 7625445
[TBL] [Abstract][Full Text] [Related]
12. [Association of beta 3-adrenergic receptor gene with obesity in patients with type 2 diabetes mellitus].
Chen Y; Xu Y; Zhou L
Zhonghua Yu Fang Yi Xue Za Zhi; 2001 Sep; 35(5):333-5. PubMed ID: 11769635
[TBL] [Abstract][Full Text] [Related]
13. Beta3-adrenergic receptor gene polymorphism is not associated with hypertension in NIDDM patients without nephropathy.
Baba T; Nakajima S; Yajima Y
Horm Metab Res; 1998 Oct; 30(10):629-32. PubMed ID: 9851671
[TBL] [Abstract][Full Text] [Related]
14. An association between the Trp64Arg polymorphism in the beta3-adrenergic receptor gene and endometrial cancer and obesity.
Babol K; Przybylowska K; Lukaszek M; Pertynski T; Blasiak J
J Exp Clin Cancer Res; 2004 Dec; 23(4):669-74. PubMed ID: 15743038
[TBL] [Abstract][Full Text] [Related]
15. Beta 3-adrenergic receptor gene variant and lipid metabolism in Pima Indians.
Tataranni PA; Pratley R; Shuldiner A; Ravussin E
Diabetologia; 1997 Jan; 40(1):123-4. PubMed ID: 9028730
[No Abstract] [Full Text] [Related]
16. Analysis of the lamin A/C gene as a candidate for type II diabetes susceptibility in Pima Indians.
Wolford JK; Hanson RL; Bogardus C; Prochazka M
Diabetologia; 2001 Jun; 44(6):779-82. PubMed ID: 11440372
[TBL] [Abstract][Full Text] [Related]
17. Organization of the human carboxypeptidase E gene and molecular scanning for mutations in Japanese subjects with NIDDM or obesity.
Utsunomiya N; Ohagi S; Sanke T; Tatsuta H; Hanabusa T; Nanjo K
Diabetologia; 1998 Jun; 41(6):701-5. PubMed ID: 9662053
[TBL] [Abstract][Full Text] [Related]
18. Polymorphism of the beta 3-adrenergic receptor gene in morbid obesity.
Oksanen L; Mustajoki P; Kaprio J; Kainulainen K; Jänne O; Peltonen L; Kontula K
Int J Obes Relat Metab Disord; 1996 Dec; 20(12):1055-61. PubMed ID: 8968849
[TBL] [Abstract][Full Text] [Related]
19. A study on the genetics of obesity: influence of polymorphisms of the beta-3-adrenergic receptor and insulin receptor substrate 1 in relation to weight loss, waist to hip ratio and frequencies of common cardiovascular risk factors.
Benecke H; Topak H; von zur Mühlen A; Schuppert F
Exp Clin Endocrinol Diabetes; 2000; 108(2):86-92. PubMed ID: 10826514
[TBL] [Abstract][Full Text] [Related]
20. The Trp64Arg polymorphism of the beta 3-Adrenergic receptor gene. Lack of association with NIDDM and features of insulin resistance syndrome.
Rissanen J; Kuopusjärvi J; Pihlajamäki J; Sipiläinen R; Heikkinen S; Vanhala M; Kekäläinen P; Kuusisto J; Laakso M
Diabetes Care; 1997 Aug; 20(8):1319-23. PubMed ID: 9250462
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
